Vik Chopra
Stock Analyst at Wells Fargo
(1.85)
# 3,142
Out of 4,893 analysts
41
Total ratings
35.29%
Success rate
-3.22%
Average return
Main Sectors:
Stocks Rated by Vik Chopra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MASI Masimo | Maintains: Overweight | $205 → $190 | $162.15 | +17.18% | 9 | May 7, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Equal-Weight | $25 → $13 | $12.64 | +2.85% | 2 | May 6, 2025 | |
| HSIC Henry Schein | Maintains: Equal-Weight | $80 → $75 | $73.55 | +1.97% | 2 | May 6, 2025 | |
| CNMD CONMED | Maintains: Equal-Weight | $70 → $57 | $51.79 | +10.06% | 4 | May 1, 2025 | |
| ALGN Align Technology | Maintains: Overweight | $255 → $246 | $202.02 | +21.77% | 2 | May 1, 2025 | |
| SOLV Solventum | Maintains: Equal-Weight | $73 → $75 | $73.93 | +1.45% | 3 | Feb 28, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Equal-Weight | $20 → $19 | $16.21 | +17.21% | 2 | Feb 28, 2025 | |
| GMED Globus Medical | Maintains: Overweight | $95 → $93 | $57.30 | +62.30% | 9 | Feb 21, 2025 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $20 → $21 | $20.27 | +3.60% | 2 | Feb 6, 2025 | |
| NPCE NeuroPace | Maintains: Overweight | $15 → $13 | $9.88 | +31.58% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $19 | $11.19 | +69.79% | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $73 → $79 | $34.26 | +130.59% | 3 | Feb 23, 2024 |
Masimo
May 7, 2025
Maintains: Overweight
Price Target: $205 → $190
Current: $162.15
Upside: +17.18%
Integra LifeSciences Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $25 → $13
Current: $12.64
Upside: +2.85%
Henry Schein
May 6, 2025
Maintains: Equal-Weight
Price Target: $80 → $75
Current: $73.55
Upside: +1.97%
CONMED
May 1, 2025
Maintains: Equal-Weight
Price Target: $70 → $57
Current: $51.79
Upside: +10.06%
Align Technology
May 1, 2025
Maintains: Overweight
Price Target: $255 → $246
Current: $202.02
Upside: +21.77%
Solventum
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $73 → $75
Current: $73.93
Upside: +1.45%
DENTSPLY SIRONA
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $16.21
Upside: +17.21%
Globus Medical
Feb 21, 2025
Maintains: Overweight
Price Target: $95 → $93
Current: $57.30
Upside: +62.30%
Envista Holdings
Feb 6, 2025
Maintains: Equal-Weight
Price Target: $20 → $21
Current: $20.27
Upside: +3.60%
NeuroPace
Nov 13, 2024
Maintains: Overweight
Price Target: $15 → $13
Current: $9.88
Upside: +31.58%
Aug 1, 2024
Maintains: Overweight
Price Target: $26 → $19
Current: $11.19
Upside: +69.79%
Feb 23, 2024
Maintains: Overweight
Price Target: $73 → $79
Current: $34.26
Upside: +130.59%